Kezar Life Sciences Inc
(NASDAQ: KZR)

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.

6.250

- (-%)
Range 6.190 - 6.268   (1.26%)
Open 6.255
Previous Close 6.250
Bid Price 2.910
Bid Volume 22
Ask Price 3.190
Ask Volume 11
Volume 37,456
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 04:59.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis